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Background: No cases of transfusion-transmitted syphilis have been described for over four decades. While there is
mandatory transfusion screening for syphilis, the absence of transmission is in part ascribed to a low prevalence of
syphilis in the blood donor population, the concomitant use of antibiotics in a high proportion of transfusion recipients,
allied with poor survival of T. pallidum during refrigerated storage of blood products.
Methods: A cross-sectional retrospective data analysis was conducted to ascertain the prevalence of Treponema
pallidum antibodies in U.S. blood donors by demography and geography. Routine blood donation testing data
and demographics were extracted from the data warehouse of a large network of U.S. blood centers. Crude and
adjusted prevalence of T. pallidum antibodies and active syphilis infection were calculated, and GIS mapping was
used to illustrate geographic distribution.
Results: The prevalence of T. pallidum seropositivity and active syphilis in first time donors was 162.6 (95% CI
145.5-181.2) per 100,000 donors and 15.8 (95% CI 10.8-22.3) per 100,000 donors, respectively. The odds of
T. pallidum seropositivity were significantly elevated in African American (OR = 18.9, 95% CI 14.2-25.2), and Hispanic
(OR = 2.8, 95% CI 2.0-3.8) as compared to Caucasian donors. Similarly, the odds of active T. pallidum infections were
significantly higher in African American (OR 15.0, 95% CI 7.0-32.3) and Hispanic (OR = 5.8, 95% CI 2.9-11.6) as compared to
Caucasian donors. Syphilis seropositivity was associated with first time blood donation, increasing age, lower education,
birth outside the US, and positive tests for HIV and HCV. Geographically, T. pallidum seropositivity was increased in
southern and western regions of the US.
Conclusions: Given the low seroprevalence of syphilis in blood donors, continued screening remains
debatable; however it may provide a public health benefit through surveillance of at-risk populations.
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Treponema pallidum subsp. pallidum (T. pallidum), the
causative agent of syphilis, is mainly transmitted through
unprotected sexual contact and transplacental spread
during pregnancy [1]. Syphilis was the first transfusion-
transmitted infection to be screened following imple-
mentation of serological screening by blood banks in
1938 [2]. Prior to testing, over 100 cases of transfusion* Correspondence: murphy@ucsf.edu
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unless otherwise stated.transmitted syphilis had been reported. Mandatory trans-
fusion screening remains, yet more than 45 years have
passed without a recorded case of transfusion-transmitted
syphilis in the US [3-5]. Low prevalence of syphilis among
blood donors, the frequent use of antibiotics in transfusion
recipients, and inability of T. pallidum to survive in refrig-
erated blood products have been cited as reasons for the
absence of cases [6]. The lack of transfusion-transmitted
syphilis has raised questions over the merits of continued
mandatory blood screening for T. pallidum.
Independent of transfusion risk, syphilis remains an im-
portant disease in the United States (US) where in 2011
alone, an estimated 55,400 individuals were diagnosedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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need to control syphilis has increased as evidence suggests
that active syphilis infections potentiate transmission of
HIV [8,9]. Although incidence has decreased, syphilis re-
mains an endemic disease in high resource settings with
sustained outbreaks in selected populations [10]. Specific-
ally, surveillance data indicate that African-Americans,
Hispanics, and other minority racial/ethnic groups as well
as men who have sex with men (MSM) are disproportion-
ately affected by syphilis [11]. Consequently, elimination
efforts have been initiated to reduce syphilis using targeted
interventions in these high risk subgroups [12,13].
Population-based syphilis seroprevalence data are im-
portant to guide mitigation efforts. The National Health
and Nutrition Examination Survey (NHANES), consid-
ered the gold standard for population-based studies, is
both costly and lacks continuous surveillance [14]. In
contrast, blood donation offers potential for real-time
surveillance and identification of high-risk groups. While
blood donors overall have lower risk due to selection,
the identification of “higher” risk groups within blood
donors could indicate that the same groups are at higher
risk within the general population. Therefore, using an
existing donor-donation database, we sought to evaluate
the epidemiology of syphilis in the blood donor popula-
tion so as to inform both the value of continued transfu-
sion screening as well as the benefit to public health.
Methods
Study population
We conducted a cross-sectional study in which syphilis
test results were reviewed in combination with demo-
graphic information on allogeneic whole blood and
apheresis donors that donated at all Blood Systems Inc.
(BSI) collection centers from January 2011 to December
2012; autologous donors were excluded from the study.
This time period was selected as it offered contemporary
and complete data at time of analysis. Demographic
data, which are routinely collected on donors, include
self-identified race/ethnicity, age, gender, maximum
educational attainment and country of birth. Both demo-
graphic information and laboratory (serologic and mo-
lecular testing) results from each blood donation were
stored in a centralized data warehouse. For the purposes
of the study, donors with multiple donations were
assigned serological status based on their final donation
during the study period. Only data from individuals who
donated successfully (i.e. a unit of blood was collected)
were evaluated. Donor status was categorized as first
time if no previous donations were documented at BSI
prior to 2011 and the donor did not return for a second
donation during the study period. Repeat donor status
was defined as having donated prior to or more than
once during the study period. We acknowledge thepossibility that donors may have previously donated at a
non-BSI blood center.
Blood Systems’ donations centers supply blood prod-
ucts to hospitals in 18 states, which are primarily distrib-
uted in the western, northern, and southern US. Donors
were geographically grouped according to their zip code
of residence on the pre-donation questionnaire. For this
study, the western region included all donors with resi-
dence located within CA, AZ, NV, NM, and UT. The
northern region included WA, OR, ID, WY, MT, CO,
KS, NE, ND, SD, MN, IA, and MO. The southern region
included TX, OK, AR, LA, MS, AL, GA, FL, SC, NC,
and TN.
The use of existing data without personal identifiers
was considered exempt from human subjects approval
by the University of California San Francisco Committee
on Human Research.
Laboratory testing
Serological testing for syphilis was performed on all
blood donations using a microhemagglutination assay
(MHA-TP) (Beckman Coulter PK TP System, Fujirebio
Diagnostics, Inc. Brea, CA) for IgG or IgM antibodies
specific for T. pallidum. If the index sample tested react-
ive, it was repeated in duplicate using the same MHA-TP
assay that was employed for the initial screening. If either
of the repeat samples tested reactive, the sample was la-
beled as repeat reactive thereby prompting quarantine of
the blood product and confirmatory testing. Confirmatory
testing was performed using an enzyme immunoassay
(EIA) (CAPTIA™ Syphilis (T. pallidum) – G, Trinity Bio-
tech USA, Jamestown, NY). A confirmed positive test re-
flects T. pallidum seropositivity, which includes both
historical and active syphilis (treponemal screening lacks
the ability to differentiate between historical vs. active
syphilis infections). The samples that were confirmed as T.
pallidum MHA seropositive were further tested using a
quantitative rapid plasma reagin (qRPR) (ASI RPR Card
Test for Syphilis, Manufacturer: Arlington Scientific, Inc.,
Springville, UT) and subsequently titered. For the purpose
of this analysis, active syphilis infections were identified by
samples reporting a reactive qRPR titer ≥ 1:8 dilution, con-
sistent with previous studies of syphilis serology [13].
Statistical analysis
Overall and subgroup-specific prevalences of T. palli-
dum seropositivity and active syphilis infection were
calculated using case definitions described above.
Syphilis seropositivity (positive MHA-TP and EIA)
prevalence was stratified by donation history (first time
vs. repeat donor) and further separated by subgroup.
Demographic variables included sex, country of birth
(US/non-US), race/ethnicity, age group, and maximum
educational attainment. In addition, crude subgroup specific
Table 1 Characteristics of the study population
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Hispanic 148,201 (19)
Asian 21,410 (3)
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that were identified through blood donor testing. Because
positive syphilis serology is rare (<1%), the prevalence per
100,000 individuals was calculated for each subgroup
with 95% confidence intervals using the Clopper-Pearson
method. Prevalence was age adjusted using the direct
method to the population represented in 2001–2004
NHANES data and limited to ages under 50 years [14].
Pearson’s χ2 test was used to evaluate differences between
proportions and χ2 for trend was also calculated.
In order to visualize the geographic distribution of T.
pallidum seropositivity, ArcGIS 9.3 (Esri, Redlands, CA)
was utilized. Donors were assigned states according to
self-reported zip code of residence at time of donation.
Only states with greater than 5,000 donors were in-
cluded. States were categorized into deciles according to
state seroprevalence per 100,000 donors.
Univariate logistic regression was used to compute
odds ratios (ORs) for factors associated with both T. pal-
lidum seropositivity and active syphilis infection. Next,
multivariate logistic regression was used to produce ad-
justed estimates of association. Variables associated with
syphilis (p < 0.10) in univariate analyses were included in
the initial multivariate models, and the final multivariate
models included all variables that remained significant in
the model (p < 0.05). The data were analyzed using Stata/
MP version 12.1 (StataCorp LP, College Station, TX).
Results
Between January 2011 and December 2012, Blood Sys-
tems collected 1,826,745 allogeneic blood donations
from 798,761 donors. On average, there were 2.3 dona-
tions per donor with a range of one to 54 donations. Do-
nors were between 16–99 years of age with the most
frequent age at donation being 18 (Table 1). There was a
slight male majority. Greater than 90% of the donors re-
ported living in the western, southern, and
northern portions of the US. The majority of donors
(64%) reported education beyond a high school diploma.
Self-reported race/ethnicity included 62% Caucasian, 4%
African American, 19% Hispanic, 3% Asian, 1% Native
American, 3% other, and 9% who declined to answer.
Syphilis seropositivity
A total of 436 of 798,761 blood donors tested positive for
T. pallidum seropositivity yielding an overall seropreva-
lence of 54.6 per 100,000 (95% CI, 49.6 to 60.0). Among
first time donors, the seroprevalence of T. pallidum sero-
positivity was 162.6 per 100,000 (95% CI, 145.5-181.2)
compared to 17.9 per 100,000 (95% CI, 14.7-21.7) in re-
peat donors. Age adjustment to the NHANES population,
limited to ages under 50 years, demonstrated a prevalence
of 63.1 per 100,000 overall, 217.3 per 100,000 in first time
blood donors and 22.2 per 100,000 in repeat donors. Atotal of 55 donors were identified as having active syphilis
infection as defined by a qRPR titer ≥ 1:8 yielding a sero-
prevalence of 6.9 per 100,000 (95% CI, 5.2 to 9.0). Table 2
examines seroprevalence of T. pallidum seropositivity and
active infection for different subgroups of donors.
Table 2 Prevalence of T. pallidum antibody and active syphilis infection by demographics and donation history
T. pallidum seropositivity — confirmed reactive treponemal tests Active infections — ≥ 1.8
dilution qRPR titer






OR (95% CI) Prevalence
per 100,000
(95% CI)




Overall 162.6 (145.5-181.2) - 17.9 (14.7-21.7) - 9.1 (7.3-11.3) 6.9 (5.2-9.0) -
Sex
Male 162.7 (138.1-190.4) 1.0 20.1 (15.4-25.9) 1.0 10.4 (7.5-14.4) 9.9 (7.1-13.5) 1.0
Female 162.6 (139.3-188.6) 1.0 (0.8-1.2) 15.8 (11.6-20.9) 1.3 (0.9-1.9) 8.1 (6.0-10.9) 3.8 (2.1-6.3) 2.1 (1.5-3.1)
Birthplace
USA 152.1 (134.0-172.0) 1.0 15.4 (12.1-19.2) 1.0 9.9 (7.7-12.8) 6.3 (4.6-8.6) 1.0
Non-USA 360.1 (276.2-461.4) 2.4 (1.8-3.1) 45.9 (26.7-73.4) 3.0 (1.8-5.1) 7.9 (4.6-13.5) 11.1 (4.1-24.1) 1.7 (0.7-4.1)
Missing 68.7 (35.5-119.9) 0.5 (0.3-0.8) 21.8 (11.9-36.4) 1.4 (0.8-2.5) 3.2 (1.5-6.9) 8.5 (3.4-17.6) 1.3 (0.6-3.0)
Race/Ethnicity
Caucasian 63.0 (48.7-80.3) 1.0 6.6 (4.3-9.7) 1.0 9.5 (6.0-15.0) 2.4 (1.3-4.2) 1.0
African American 1183.7 (994.7-1397.8) 19.0 (14.1-25.6) 199.5 (139.7-276.0) 30.1 (18.2-49.9) 6.0 (4.2-8.7) 57.4 (33.4-91.9) 23.7 (11.3-49.6)
Hispanic 188.1 (150.9-231.6) 3.0 (2.2-4.1) 35.5 (24.9-49.2) 5.4 (3.2-8.9) 5.3 (3.6-7.8) 16.9 (10.9-24.9) 7.0 (3.5-13.8)
Asian 75.2 (24.4-175.5) 1.2 (0.5-3.0) 6.8 (0.2-37.7) 1.0 (0.1-7.5) 11.1 (1.3-95.2) 0 (0.0-17.2) 0 (−)
Native American 118.5 (32.3-303.2) 1.9 (0.7-5.2) 15.7 (0.4-87.3) 2.4 (0.3-17.4) 7.6 (0.8-67.8) 0 (0.0-37.8) 0 (−)
Other 113.3 (48.9-223.1) 1.8 (0.9-3.7) 6.7 (0.2-37.1) 1.0 (0.1-7.4) 17.0 (2.1-136.3) 4.5 (0.1-25.2) 1.9 (0.2-14.4)
Unknown 92.6 (58.0-140.1) 1.5 (0.9-2.4) 12.2 (4.5-26.7) 1.8 (0.8-4.5) 7.6 (3.1-18.7) 0 (0.0-5.1) 0 (−)
Age
16-19 16.3 (8.67-27.9) 1.0 8.6 (3.5-17.7) 1.0 1.9 (0.8-4.8) 7.4 (3.9-13.0) 1.0
20-29 116.5 (88.2-150.9) 7.2 (3.9-13.1) 29.3 (20.3-41.0) 3.4 (1.5-7.7) 4.0 (2.6-6.1) 16.4 (10.8-23.8) 2.2 (1.1-4.3)
30-39 225.8 (172.7-289.9) 13.9 (7.6-25.3) 19.4 (11.3-31.2) 2.3 (0.9-5.5) 11.6 (6.8 (19.9) 6.1 (2.5-12.6) 0.8 (0.3-2.1)
40-49 497.1 (405.9-602.5) 30.7 (17.2-54.7) 27.5 (18.1-40.0) 3.2 (1.4-7.3) 18.2 (11.9-27.8) 5.9 (2.4-12.1) 0.8 (0.3-2.0)








< High school 79.7 (59.3-104.7) 1.0 19.0 (10.9-30.9) 1.0 4.2 (2.4-7.4) 10.8 (6.2-17.5) 1.0
High school 427.4 (347.8-519.5) 5.4 (3.8-7.5) 20.3 (11.8-32.5) 1.1 (0.5-2.1) 21.2 (12.7-35.4) 9.3 (4.5-17.2) 0.9 (0.4-1.9)
Some college 184.7 (151.3-223.4) 2,3 (1,7-3.2) 24.3 (18.1-31.9) 1.3 (0.7-2.2) 7.6 (5.5-10.7) 8.6 (5.5-12.9) 0.8 (0.4-1.5)
BS/BA 159.4 (110.4-222.7) 2.0 (1.3-3.1) 9.2 (4.4-16.9) 0.5 (0.2-1.1) 17.4 (8.6-35.1) 3.1 (0.8-7.9) 0.3 (0.1-0.8)
MS/PhD 100.6 (71.3-152.8) 1.3 (0.8-2.1) 7.9 (2.1-20.1) 0.4 (0.1-1.2) 12.8 (3.9-41.7) 1.7 (0.04-9.3) 0.2 (0.0-1.2)








First time 15.8 (10.8-22.3) 1.0
Repeat 3.9 (2.4-5.8) 4.1 (2.4-7.0)
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creased more than 9-fold in first time donors as compared
to repeat donors. In addition, with the exception of the
16–19 year old age group, T. pallidum seropositivity wassignificantly (p < 0.05) greater in first time compared to re-
peat donors across all demographic subgroups (Table 2).
Among first time donors, both African Americans (1183.7;
95% CI 994.7-1397.8) and Hispanics (188.1; 95% CI 150.9-
Kane et al. BMC Infectious Diseases  (2015) 15:63 Page 5 of 9231.6) had significantly (p < 0.0001) higher seroprevalence
than Caucasians (63.0; 95% CI 48.7-80.3). The χ2 test for
trend indicated that seroprevalence among first time do-
nors increased with age category (p < 0.0001).
Figure 1 shows the geographic distribution of T. palli-
dum seropositivity among blood donors by residence. Sero-
prevalence was highest in the southern states of Louisiana,
Mississippi, and Texas. The majority of states located in
the northern region were categorized in the lowest deciles
including Oregon, Idaho, Montana, and Minnesota.
Multivariate logistic regression was performed to esti-
mate independent associations of the various demographic
and geographic factors of T. pallidum seropositivity
(Table 3). Seropositivity was associated with first time
donor status as well as African American, Hispanic, Other
and Unknown race/ethnicity. African Americans had 18
times the odds of testing seropositive for T. pallidum as
compared to Caucasians (OR 18.9; 95% CI 14.2-25.2), after
adjusting for other factors. A positive HIV or HCV test re-
sult was associated with syphilis seropositivity although
the confidence intervals are wide (OR 16.6; 95% CI 4.5-
60.5 and OR 7.6; 95% CI 3.9-14.7, respectively). As age in-
creased, the odds of seropositivity also increased and as
education level increased, seropositivity decreased. Blood
donors born within the US were less likely to have evi-
dence for seropositivity and those residing in western andFigure 1 Prevalence of T. pallidum seropositivity according to state of r
white being lowest and black highest.southern states were more likely to be seropositive for
syphilis than those in northern states.Active syphilis
The prevalence of active syphilis infection (qRPR titers ≥
1:8) was also analyzed by demographic subgroup (Table 2).
Prevalence was significantly higher in males as compared
to females (p = 0.001) and in first time donors as com-
pared to repeat donors (p < 0.001). The prevalence of ac-
tive syphilis infection in African Americans (57.4; 95% CI
33.4-91.9) was significantly (p < 0.0001) greater than in all
other race/ethnicity subgroups; Hispanic (16.9; 95% CI 10.9-
24.9) blood donors had a significantly (p < 0.0001) higher
prevalence of active infection compared to Caucasians
(2.4; 95% CI 1.3-4.2). Unlike the seropositivity results, the
20–29 age group had the highest prevalence of active in-
fection while the 50+ age group had the lowest. There was
also an inverse relationship between age group and active
syphilis infection (p < 0.0001, X2 trend). Those without a
high school diploma had significantly higher prevalence
when compared to those who completed higher educa-
tion (ie. BA/BS, MS/PhD, p = 0.0124, data not shown).
There was an inverse relationship between educational
achievement and active syphilis infections (p = 0.0003,
X2 test for trend).esidence. Seroprevalence (in deciles) is represented in grey-scale, with
Table 3 Independent predictors of T. pallidum
seropositivity: odds ratios and 95% confidence intervals
from the multivariate logistic regression model
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Table 4 Independent predictors of active syphilis
(qRPR > = 1:8): odds ratios and 95% confidence intervals
from the multivariate logistic regression model









First Time 2.9 [1.7-5.1]
Race/Ethnicity
Caucasian 1.00
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tion was independently associated with age (20–29
years), first time donor status and African American and
Hispanic race/ethnicity. Females were less likely to be
positive for active syphilis infection than males. A concur-
rent positive HIV test result was associated with increased
odds of active syphilis infection although the confidence
interval was wide (OR 208.0; 95% CI 56.6-764.2) (esti-
mates were based on only three co-infections).Discussion
We report a low seroprevalence of T. pallidum seroposi-
tivity in US blood donors: 162.6 and 17.9 per 100,000 in
first time and repeat donors, respectively. In contrast,
the NHANES 2001–2004 reported an overall seropreva-
lence of 710 per 100,000 individuals in the US general
population using a comparable testing strategy [14]. After
age-adjustment, the NHANES results were still over
three times higher than our first time donor population.
However, lower prevalence estimates than previous na-
tional surveillance studies were observed in African
American and Hispanic race/ethnicities, which is similar
to NHANES and syphilis case surveillance data [14-17].
Furthermore, we noted regional differences in syphilis
donor seroprevalence, which was higher in those living in
the southern than western or northern regions. There
were far fewer cases of active syphilis infection (15.8 per
100,000 in first time donors) than cases of seropositivity.
NHANES reported a prevalence of active syphilis of 80
per 100,000 in the general population, using the same
definition as our study (qRPR ≥ 1:8).
In NHANES 2001–2004 study of syphilis serology, in-
vestigators reported large racial/ethnic differences be-
tween Caucasians and African-Americans. Gottlieb et al.
reported an unadjusted prevalence (seropositivity) ratio
of 61:1 for African-Americans compared to Caucasians
[13,14]. In contrast, the prevalence ratio of African-
Americans to Caucasians in our study was 18.8:1 in first
time donors. First time donors are thought to offer a
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population given that, unlike repeat donors, they have
not been tested previously and are less affected by selec-
tion bias. Nevertheless, selection bias inherent to blood
donation, which excludes high-risk behaviors and favors
higher educational status, may account for the observed
reduced race/ethnicity ratio as compared to that of Gottlieb
et al. Similarly the seropositivity prevalence ratio of first
time Hispanics to Caucasian blood donors was 2.98:1. Al-
though reduced, this still supports mitigation efforts in
the African American and Hispanic communities.
The geographic distribution of T. pallidum seroposi-
tivity in blood donors was similar to the distribution of
reported primary and secondary syphilis cases in 2012
[11]. In our study, Louisiana demonstrated the highest
seroprevalence of T. pallidum. However, our data set in-
cluded uneven sampling of blood donors in each state,
which introduces potential for unstable estimates. For
example, per the CDC data, a high rate of increase in
primary and secondary syphilis was reported in the
Northeast [11] where BSI centers are under-represented.
This highlights opportunity for a collaborative effort be-
tween blood banks and state or national reporting bodies
to provide more stable estimates, which are not neces-
sarily confined to high-risk groups. For example, similar
surveillance could be performed for other infections that
are routinely screened in the donor population such as
HIV, HBV, HCV, HTLV, West Nile Virus and T. cruzi.
We observed interesting patterns of age specific T.
pallidum seropositivity and active syphilis infection. The
prevalence of T. pallidum seropositivity increased with
age. This likely reflects cumulative incidence: low level
of antibodies to T. pallidum may be produced for de-
cades following an infection. Because treponemal tests
detect antibodies specific for T. pallidum antigens,
treponemal tests report cumulative incidence rather than
current infection. Another possible explanation for the
relationship between age and T. pallidum seropositivity
includes a birth cohort effect, whereby older cohorts
may have been sexually active during times when T. pal-
lidum transmission was more common. It is difficult to
differentiate between these explanations without add-
itional years of data detailing the rate of syphilis infec-
tion. For active syphilis (qRPR titers ≥1:8), a different
age pattern emerged, whereby the 20–29 year age group
had the highest prevalence. Young age is associated with
increased sexual activity, which is a well-characterized
risk factor for developing a syphilis infection [18]. Im-
portantly, the rates of primary and secondary syphilis
were highest in this same age group in the CDC surveil-
lance data from 2012 [11].
An inverse relationship was observed between educa-
tional attainment and T. pallidum seropositivity. Re-
duced access to treatment and preventive measures mayaccount for this finding in low socioeconomic groups.
There was also a significantly higher prevalence of active
syphilis in males as compared to females, which is con-
sistent with recent reports in which the ratio of males to
females with syphilis (primary and secondary) increased
from 1.5 in 2000 to 8.2 in 2011 [19]. This is largely as-
cribed to increases in cases of syphilis among MSM [11],
which suggests that MSM may be represented among
blood donors despite FDA-mandated permanent deferral
of any donor who has had MSM since 1977. The latter
is in process of revision.
Although HIV positive donors had an increased preva-
lence of T. pallidum seropositivity and active syphilis
infection compared to HIV negative donors, very few
co-infections were detected resulting in unstable esti-
mates. Other studies have confirmed that reactive syph-
ilis serological tests or a history of genital ulceration are
strongly associated with HIV infection [8,9]. HCV infec-
tion was also associated with T. pallidum seropositivity.
Recent studies by Terrault et al. have suggested that sex-
ual transmission of HCV among heterosexual couples is
rare (1 per 190,000 sexual contacts) making sexual trans-
mission an unlikely reason for this association [20].
Other explanations for this association include evidence
that HCV infection increases the likelihood of a bio-
logical false positive test for syphilis although this is lim-
ited to qRPR tests, not specific treponemal tests [21].
HCV seropositivity is also associated with male sex and
lower education, and may be a surrogate marker for in-
jection drug use and high-risk sexual behavior.
The cost utility of mandatory screening has been ques-
tioned in the US given the low prevalence of active syph-
ilis infection in donors and the inability of T. pallidum
to survive refrigeration. One argument for continued
screening has been the notion that syphilis is a surrogate
marker for transfusion transmitted HIV. However, our
study showed this not to be the case whereby we ob-
served a very low positive predictive value of only 3 of
936 (0.32%) cases of HIV co-infection. Nonetheless, des-
pite limited utility to blood safety in the US, syphilis
screening offers public health benefit through identification
of a small number of active syphilis cases. More import-
antly, the data it provides may be useful for population
surveillance.
Our analysis had several strengths. First, it informs
discussion surrounding the utility of continued syphilis
screening. Second, the described testing was performed
in a highly regulated environment, ensuring a high quality
of laboratory data. Third, the sample size was sufficiently
large to enable calculation of syphilis seroprevalence by
minority population and geography.
However, our study also had limitations. First, qRPR
testing lacks sensitivity in late stages of syphilis; there-
fore we may have underestimated the prevalence of
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to differentiate syphilis from other pathogenic trepo-
nemes such as T. pallidum subsp. pertenue, endemicum
and carateum, the causative agents of yaws, bejel, and
pinta respectively [22]; however, we expect misclassifica-
tion due to cross-reactivity with other treponemes to be
minimal due to the rarity of such infections in the US.
Third, the selection bias inherent to low risk volunteer
blood donors results in underestimation of syphilis sero-
prevalence in the general population. However, we show
that subgroup-specific differences are preserved. There
may be additional geographic bias due to our use of data
from the BSI network, which is focused in the western,
southern and northern United States. Fourth, although the
likelihood of transmission of syphilis via transfusion is low
for the reasons cited (e.g. intolerance of refrigeration), one
cannot discount the relative contribution of screening to
reduction in risk. However, despite a changing seropreva-
lence, the absent transmission over four decades does sup-
port the notion that screening is only one of several
factors that influence risk. Fifth, although higher rates of
primary and secondary syphilis have been described in the
younger age groups, we elected to retain those over age 50
given that a proportion of cases do occur in this group
(most notably in males) [11]. In so doing the NHANES
data may not be directly comparable given a restriction to
age less than 50 years. Finally, we used operational data
and no sexual risk behavior information was included in
our analysis.
Conclusions
In conclusion, the prevalence of T. pallidum seropositiv-
ity and active syphilis infection remains low in US blood
donors. However, among donors, African-American and
Hispanic race/ethnicities and residence in the southern
US were associated with T. pallidum seropositivity. While
the merits of screening blood to prevent transfusion-
transmitted T. pallidum remain debatable, donor testing
continues to offer public health benefit. Ongoing infec-
tious disease surveillance that leverages the networks of
US blood collection and testing centers offers a valuable
but underutilized public health resource.
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